$2.34 -0.02 (-0.85%) Rigel Pharmaceuticals Inc - NASDAQ

Feb. 10, 2016 | 04:00 PM
Key Statistics
Last Trade: 2.34
Trade Time: Feb 10 04:00 PM Eastern Daylight Time
Change: -0.02 (-0.85%)
Prev Close: 2.36
Open: 2.37
Bid: 2.34
Ask: 2.35

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 44.68M +1.34%
MSTX Mast Therapeutics Inc 14.39M -44.59%
MRK Merck & Co Inc 11.03M +0.75%
MYL Mylan N.V. 10.61M -0.39%
JNJ Johnson & Johnson 9.82M -0.24%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST